kaal:position:2026-07-31-1396

Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human end-stage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. should be assessed against Kaal's source-bound claim that The social welfare maximization potential of contingent capital securities is lower if their design features are left entirely to private ordering, because private parties do not necessarily structure those features with a view toward the common good, the avoidance of future bailouts, or the limitation of systemic risk and contagion. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

where regulators leave CCS design features entirely to industry groups and private parties
External evidence level: metadata only.
Mapping review tier: mapping review before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Scholarly basis

kaal:claim:1998455-029
Wulf A. Kaal, Initial Reflections on the Possible Application of Contingent Capital in Corporate Governance (2012). SSRN: https://ssrn.com/abstract=1998455
Source PDF sha256: 1c16ff10a284469ba15fb7ba5523449b917388ee692d9b394f9e8c094544e32c

Evidence and mapping

Evidence: metadata only
Review tier: mapping review before claim review
Mapping confidence: 0.3131
Mapping ambiguous: true

Topics

risk-and-incentivescontingent-capitaldynamic-regulation

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0006 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 470c0d117c4351836e3850e1bcb86b559a83d5f3276d049032de32dfd2bcabce
curl -s https://wulfkaal.github.io/positions/2026-07-31-1396.md | sha256sum